BlackRock Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

BlackRock Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.43M	Sell	25,686 -384	-1%	-$18.5K	﹤0.01%	1679
2016 Q3	$1.19M	Buy	26,070 +332	+1%	+$13.3K	﹤0.01%	1728
2016 Q2	$1.03M	Buy	25,738 +287	+1%	+$10.5K	﹤0.01%	1753
2016 Q1	$886K	Buy	25,451 +444	+2%	+$16.3K	﹤0.01%	1798
2015 Q4	$1.07M	Sell	25,007 -2,421	-9%	-$121K	﹤0.01%	1672
2015 Q3	$1.19M	Sell	27,428 -3,543	-11%	-$191K	﹤0.01%	1581
2015 Q2	$1.6M	Sell	30,971 -30,497	-50%	-$1.3M	﹤0.01%	1377
2015 Q1	$2.41M	Buy	61,468 +2,289	+4%	+$89.7K	﹤0.01%	1163
2014 Q4	$2.29M	Buy	59,179 +605	+1%	+$23.1K	﹤0.01%	1158
2014 Q3	$2.07M	Sell	58,574 -10,461	-15%	-$307K	﹤0.01%	1166
2014 Q2	$1.86M	Sell	69,035 -31,251	-31%	-$814K	﹤0.01%	1194
2014 Q1	$2.6M	Sell	100,286 -207,347	-67%	-$4.97M	﹤0.01%	1115
2013 Q4	$6.67M	Sell	307,633 -90,971	-23%	-$1.86M	0.01%	926
2013 Q3	$7.76M	Sell	398,604 -421,410	-51%	-$7.47M	0.01%	856
2013 Q2	$12.8M	Buy	+820,014	New	+$13.2M	0.01%	697

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

BlackRock Advisors's BSTC Position: Q4 2016 in Review

BlackRock Advisors reduced its BioSpecifics Technologies Corp. (BSTC) stake by 1.5% in Q4 2016, selling an estimated $18.5K and leaving 25,686 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

BlackRock Advisors first reported a position in BSTC in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.8M in Q2 2013. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

BlackRock Advisors held 25,686 shares of BioSpecifics Technologies Corp. worth $1.43M as of Q4 2016.
BlackRock Advisors sold 384 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $18.5K.
BioSpecifics Technologies Corp. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1679 holding.
BlackRock Advisors first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's BioSpecifics Technologies Corp. position peaked at $12.8M in Q2 2013.
96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.